SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0221
Iv0222
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Neutralization
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
SevereAcuteRespiratorySyndromeCoronavirus2(SARS-CoV-2)
Research Grade Biosimilar
IgG1-lambda
SARS-CoV-2
IgG1
SARS-CoV-2(2019-nCoV)
IgG1, lambda2
E. coli
P0DTD1
Asp4891-Val5212
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)